Incendia Therapeutics Email Formats
Biotechnology Research • 
Cambridge, Massachusetts, United States • 21-50 Employees
Incendia Therapeutics Email Formats
Incendia Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@incendiatx.com), used 93.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@incendiatx.com | 93.3% |
{first initial}.{last name} | j.doe@incendiatx.com | 6.7% |
Key Contacts at Incendia Therapeutics
Wendye Robbins
President And Chief Executive Officer
Xinwei Sher
Director Of Data Science
Micah Minich
Director, Site Contracts And Budgets
James Corkery
Director, Clinical Operations
Heather Condurso
Director
Yan Qin
Associate Director
Company overview
| Headquarters | 1 Canal Park, Suite 200, Cambridge, Massachusetts 02141, US |
| Website | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
About Incendia Therapeutics
Incendia Therapeutics is a clinical-stage biotechnology company discovering and developing novel monoclonal antibody therapies that disrupt the tumor microenvironment (TME) to improve cancer outcomes. The Company’s science is targeting immune-excluded tumors, an identifiable, prevalent solid tumor phenotype. Incendia’s unique approach breaks down physical and biochemical barriers within the TME to enhance host immune cell infiltration into tumors and enable cancer therapeutics to reach their targets across a broad range of solid cancers. Incendia believes that there are multiple novel opportunities within the TME to target treatment of cancer and improve outcomes. Incendia’s most advanced investigational therapeutic is PRTH-101, a novel therapeutic antibody that binds to and inhibits Discoidin Domain Receptor 1 (DDR1), an element of the TME that is highly expressed by cancer cells in multiple solid tumor types. The Company is currently recruiting patients into a Phase 1c clinical trial with PRTH-101 for the treatment of patients with advanced solid tumors (thymic carcinoma).
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Incendia Therapeutics has 11 employees across 8 departments.
Departments
Number of employees
Funding Data
Incendia Therapeutics has never raised funding before.
Incendia Therapeutics Tech Stack
Discover the technologies and tools that power Incendia Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Tag managers
Hosting
Webmail
Miscellaneous
Analytics
JavaScript libraries
Italy
Norway
Netherlands
United Kingdom
Israel
Spain
CanadaFrequently asked questions
4.8
40,000 users
